BPC-157
Shop BPC-157Also called: Body Protection Compound, PL 14736, BPC-157 + Collagen Plus
BPC-157 is a man-made copy of a tiny piece of protein found in the juice of your stomach. The letters stand for Body Protection Compound, and 157 is the number of the piece scientists found. It is sold as a powder or liquid that people inject or swallow. It is not an approved medicine in most places. Gym-goers, athletes, and people with sore joints often buy it online hoping it will heal injuries faster.
In lab and animal tests, BPC-157 seems to help the body repair itself. In rats with cut Achilles tendons, the treated rats healed better and moved around sooner than untreated rats. It may also help grow new tiny blood vessels, which brings more blood and healing to damaged tissue. This is why people hope it might help tendons, muscles, ligaments, and the gut. Almost all of this proof comes from rats and mice, not people.
Here is the big caution: there is very little research in humans. One big review of studies found almost all the work was done in animals, and there was almost no safety data in people. Government health groups, like the FDA in the United States and ANMAT in Argentina, warn that products sold online may be impure, mislabeled, or unsafe. Buying these products from websites can be a real gamble with your health. Talk to a doctor before trying anything like this.
Building Blocks
BPC-157 in Stacks & Blends
BPC-157 is one of the building blocks in these 2 blends and stacks people actually buy:
Regulatory status
On July 23, 2026, the FDA Pharmacy Compounding Advisory Committee (PCAC) voted 8–6–1 to recommend adding BPC-157 to the Section 503A Bulks List. The recommendation is advisory only — FDA must still complete formal notice-and-comment rulemaking, typically 12–24 months. BPC-157 is not currently on the 503A Bulks List, remains an unapproved new drug under the FD&C Act, and cannot lawfully be compounded by traditional 503A pharmacies in the interim.
Benefits
What BPC-157 Helps With
The main themes across 185 research studies, in plain language.
Tissue & wound healing
Wound healing & skin regeneration
95/100Rated 95/100Source typePeer-reviewed studyIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 98 underlying claimsFindings suggest it accelerates the closure of skin wounds, burns, and ulcers while enhancing collagen production.
Cell migration & tissue remodeling
95/100Rated 95/100Source typePeer-reviewed studyIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 79 underlying claimsFindings suggest it enhances the movement of cells to injury sites and supports the structural remodeling of tissues.
Fistula & tissue defect healing
90/100Rated 90/100Source typePeer-reviewed studyIndependent sources4Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 21 underlying claimsResearch highlights its ability to promote the closure of complex tissue openings and fistulas in various animal models.
Musculoskeletal
Tendon, ligament & muscle repair
90/100Rated 90/100Source typePeer-reviewed studyIndependent sources4Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 234 underlying claimsResearch suggests the peptide accelerates the healing of connective tissues, improves tendon-to-bone integrity, and speeds recovery from muscle injuries.
Bone health & fracture support
50/100Rated 50/100Source typeUnclassified sourceIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 42 underlying claimsPreliminary research indicates it may stimulate bone-building cells and accelerate the healing of fractures and defects.
Research examples
- Promotes osteoblast activity and restrains osteoclastogenesis
- Accelerated bone defect repair and shifts balance toward osteoblast activity
- Enhanced bone healing, osteogenesis, and earlier callus formation
Gut lining repair & ulcer healing
85/100Rated 85/100Source typePeer-reviewed studyIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 189 underlying claimsStudies indicate it helps heal stomach and intestinal ulcers, protects the gut lining from NSAID damage, and repairs leaky gut.
Anti-inflammatory & pain modulation
50/100Rated 50/100Source typeUnclassified sourceIndependent sources5Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 115 underlying claimsResearch suggests it reduces systemic inflammation, modulates key cytokines, and may help alleviate chronic pain.
Cellular defense & cytoprotection
90/100Rated 90/100Source typePeer-reviewed studyIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 65 underlying claimsStudies suggest it helps maintain cellular integrity, protects against oxidative stress, and stabilizes cell functions.
Metabolic & organ function support
85/100Rated 85/100Source typePeer-reviewed studyIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 34 underlying claimsLimited evidence suggests it may support metabolic regulation and protect organs like the liver and heart from toxin-induced damage.
Angiogenesis & blood vessel formation
50/100Rated 50/100Source typeUnclassified sourceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 128 underlying claimsEvidence points to the stimulation of new blood vessel growth and improved blood flow, which may aid in tissue recovery.
Neuroprotection & nerve recovery
95/100Rated 95/100Source typePeer-reviewed studyIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →· 87 underlying claimsAnimal studies show potential for protecting brain cells, aiding recovery from nerve injuries, and improving functional outcomes after trauma.
Free: The Peptide Stack Cheat-Sheet
See where BPC-157 fits — the most-used combinations, dosing notes from the research, and what to check before you buy.
No spam. Unsubscribe anytime.
How People Use It
1 reported routine — each line links to the source it came from.
Self-reported & vendor-suggested
Routines shared by users and sellers in forums and product pages — anecdotal, not tested in clinical trials. We show them for completeness, not as a recommendation.
SubQ
- BPC-157 250–500 mcg/day SC + TB-500 2–5 mg twice weekly for 4–6 week loading, then TB-500 2 mg weekly for 4–8 weeks 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
mg vs mcg: one milligram (mg) equals 1,000 micrograms (mcg) — multiply by 1,000 going from mg to mcg, divide by 1,000 going from mcg to mg. Mixing the two up is a thousand-fold dosing error: 1 mg taken instead of 1 mcg is a 1,000× overdose; 1 mcg instead of 1 mg is a 1,000× underdose. Always double-check the unit label and the decimal place.
Honest expectations
What BPC-157 doesn’t do
What the sourced research says it doesn’t do — as notable as what it does.
- Stimulates lipolysis and inhibits lipogenesis without growth-promoting effects 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↵ source
Safety
Known Side Effects
Adverse effects reported in the research and by community use.
- Hormonal imbalanceModerate 90/100Rated 90/100Source typeRegulator or clinical registryIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ recalls-rappels.canada.ca
- Mood swingsMild 90/100Rated 90/100Source typeRegulator or clinical registryIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ recalls-rappels.canada.ca
- Blood sugar imbalanceModerate 90/100Rated 90/100Source typeRegulator or clinical registryIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ recalls-rappels.canada.ca
- Kidney damageSevere 90/100Rated 90/100Source typeRegulator or clinical registryIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ recalls-rappels.canada.ca
- Blood clotsSevere 90/100Rated 90/100Source typeRegulator or clinical registryIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ recalls-rappels.canada.ca
- Growth of cancerous tumoursLifeThreatening 90/100Rated 90/100Source typeRegulator or clinical registryIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ recalls-rappels.canada.ca
- InfectionsModerate 90/100Rated 90/100Source typeRegulator or clinical registryIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ recalls-rappels.canada.ca
- Pain and Necrosis at Injection SiteModerate 80/100Rated 80/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ pmc.ncbi.nlm.nih.gov
- Allergic reactions including severe ones like anaphylaxisLifeThreatening 75/100Rated 75/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ health.harvard.edu
- Autoimmune issuesSevere 70/100Rated 70/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ health.harvard.edu
- Human safety unproven — FDA advisors flagged risksSevere 60/100Rated 60/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ biopharmadive.com
- Injection site reactionsMildReported in 18 sources 60/100Rated 60/100Source typeSpecialist communityIndependent sources18Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptideassociation.org↗ theconversation.com↗ theguardian.com↗ peptideassociation.org+14
- Transient headacheMild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptideassociation.org
- Mild fatigueMildReported in 3 sources 60/100Rated 60/100Source typeSpecialist communityIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptideassociation.org↗ peptide-db.com↗ peptide-db.com
- GI upsetMild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptideassociation.org
- PalpitationsModerateReported in 2 sources 60/100Rated 60/100Source typeSpecialist communityIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptideassociation.org↗ allaboutpeptides.com
- Altered glucose metabolismModerate 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptideassociation.org
- DysesthesiaModerate 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org
- Nasal irritationMild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ peptidepedia.org
- Nausea (most common with PT-141, sometimes severe enough for ondansetron prophylaxis)Moderate 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ excelmale.com
- Facial flushing with PT-141Mild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ excelmale.com
- Injection-site reactions with PT-141Mild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ excelmale.com
- Headache with PT-141Mild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ excelmale.com
- Transient blood pressure elevation with PT-141Moderate 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ excelmale.com
- Tanning effect (melanocortin crossover)Mild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ excelmale.com
- Cortisol and prolactin elevation at supra-saturation ghrelin mimetic dosesMild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ excelmale.com
- Tachyphylaxis with repeated PT-141 dosingMild 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ excelmale.com
- Local infections and systemic sepsis from contaminated gray-market injectablesSevere 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ excelmale.com
Reported in research and community sources — not exhaustive. Discontinue use and consult a healthcare professional if side effects occur.
Get BPC-157
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
Technical Details (sequence & mechanism — click to expand)
Amino Acid Sequence
Mechanism of Action
Pentadecapeptide isolated from human gastric juice with pleiotropic tissue-repair effects. Promotes tendon/ligament healing via fibroblast proliferation and migration, upregulates growth hormone receptor expression on tendon fibroblasts, stimulates angiogenesis and collagen synthesis, and exerts anti-inflammatory/cytoprotective effects. Evidence is predominantly preclinical (in vitro and animal).
Evidence
Research Citations (50)
Every claim above traces back to a source you can check — here are 50 of them.
- Source
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.
In vitro2010 Key study 85/100Rated 85/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.
Review2019 80/100Rated 80/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts
In vitro2018 84/100Rated 84/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing
Review2025 76/100Rated 76/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts
95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
Bpc-157 | C62H98N16O22 | CID 9941957 - PubChem
95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing.
2018 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
Stable gastric pentadecapeptide BPC 157 in honeybee (Apis mellifera) therapy, to control Nosema ceranae invasions in apiary conditions.
2018 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
Counteraction of perforated cecum lesions in rats: Effects of pentadecapeptide BPC 157, L-NAME and L-arginine.
2018 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine.
2018 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights.
2017 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
Rat inferior caval vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157.
2018 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
Celecoxib-induced gastrointestinal, liver and brain lesions in rats, counteraction by BPC 157 or L-arginine, aggravation by L-NAME.
2017 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in broiler chicks.
1997 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology → - Source
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.
2011 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
Timeline
History & Milestones
Key moments in BPC-157’s research and regulatory timeline — sourced and dated.
- Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal HealingPublicationDec 1, 2025Related:BPC-157
- Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic ReviewPublicationJul 31, 2025Related:BPC-157
- Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent ReviewPublicationJan 30, 2025Related:BPC-157
- Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart MusclePublicationDec 12, 2022Related:BPC-157
- Stable Gastric Pentadecapeptide BPC 157 and Wound HealingPublicationJun 29, 2021Related:BPC-157
- Gastric pentadecapeptide BPC 157 and soft tissue healingPublicationAug 1, 2019Related:BPC-157
- Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in ratsPublicationJul 2, 2019Related:BPC-157
- The promoting effect of pentadecapeptide BPC 157 on tendon fibroblast migrationPublicationMar 1, 2011Related:BPC-157
News
Latest on BPC-157
Dated, sourced reporting that mentions BPC-157.
Peer-Reviewed Review of BPC-157 Maps Healing Mechanisms but Calls for Rigorous Human Trials
A comprehensive 2025 narrative review in Current Reviews in Musculoskeletal Medicine by McGuire et al. synthesized the evidence on BPC-157 for musculoskeletal injury, detailing its pro-angiogenic and anti-inflammatory mechanisms. The authors documented only three small human pilot studies to date, including a 2025 first-in-human IV infusion trial in two healthy adults that reported no adverse events. Despite robust preclinical signals across tendon, muscle, and bone repair, the review concluded BPC-157 remains investigational pending well-designed clinical trials.
New York Times sorts peptide-therapy hype from evidence across skincare, muscle-building, and longevity
A November 2025 New York Times explainer takes a skeptical consumer lens to the peptide-therapy craze, separating the few uses with reasonable evidence (topical GHK-Cu and Matrixyl-type peptides in skincare) from the largely unproven injectable and "biohacking" market (BPC-157, TB-500, epitalon, semax, selank). Dermatologists frame cosmetic peptides as "sidekicks, not hero ingredients," while endocrinologists warn that growth-hormone-releasing peptides like sermorelin and tesamorelin carry the same long-term risks as HGH — diabetes, certain cancers, and acromegaly. The piece notes that most longevity claims rest on cell-culture or animal data only, and that "research-grade" products have no quality controls.
CNN investigation: wellness influencers drive boom in unapproved "research-use-only" peptides
A November 2025 CNN report documents how celebrities and wellness influencers are fueling mass consumer use of unapproved peptides like BPC-157, TB-500, ipamorelin, and CJC-1295, many sold with a "for research use only" label that lawyers and regulators describe as a loophole to evade FDA oversight. Health Secretary Robert F. Kennedy Jr. has vowed to end the agency's "war on peptides," while named sellers such as biohacker Gary Brecka market injectable vials for $350 to $600 each. Independent experts — including Scripps' Dr. Eric Topol and UC Davis biologist Paul Knoepfler — stress that none of these compounds have passed adequate clinical trials and that "research-grade" powders often contain contaminants. BPC-157 and TB-500 are also banned by international sports authorities as doping substances.
RFK Jr.'s peptide push could unleash risky drugs | STAT First Opinion
This opinion piece criticizes Health Secretary RFK Jr. for reportedly moving to reverse the FDA's 2023 safety classification of certain peptides, specifically BPC-157 and GHK-Cu. The author argues that returning these substances to a status that allows compounding pharmacies to produce them ignores the lack of clinical trial data and poses significant risks to the public.
FDA PCAC 2026: committee backs six peptides for compounding, rejects Emideltide
On July 23–24, 2026, the FDA's Pharmacy Compounding Advisory Committee recommended adding six of seven reviewed peptides (BPC-157, KPV, TB-500, MOTS-c, Epitalon, Semax) to the Section 503A Bulks List and rejected Emideltide/DSIP. The vote is advisory only — not a final FDA decision and not legal authorization to compound. FDA must still complete formal notice-and-comment rulemaking (typically 12–24 months) before any change in legal status.
Wondering how BPC-157 pricing compares across suppliers? Our original market data shows the full picture.
See the State of the Peptide Market 2026 →Related on The Health Stacks
Explore by goal